Test Price
1,000 AED✅ Home Collection Available
Kidney Stone Formation Therapeutic Monitoring Panel in UAE | 1000 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed healthcare professionals.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This Therapeutic Monitoring Panel quantifies urinary lithogenic and inhibitory factors to guide management of recurrent nephrolithiasis. It provides same-day reporting using advanced spectrophotometry, enzymatic, and indirect ion-selective electrode (ISE) methods, enabling precise therapeutic adjustments and dietary modifications based on comprehensive metabolic profiling.
| Feature | Our Test (DHA-Approved) | Standard Lab Panel |
|---|---|---|
| Precision / Method | Spectrophotometry, Enzymatic, Indirect ISE | Often limited to dipstick or basic biochemistry |
| Turnaround Time | Same day (sample submission by 9 AM Wed/Sat) | 3–5 working days |
| Price | 1000 AED | Varies; often higher for comprehensive profile |
Physician Insight & Safety Protocols
“As a DHA-licensed General Practitioner, I recognize that recurrent kidney stone formation requires careful metabolic monitoring. This comprehensive panel evaluates urinary lithogenic and inhibitory factors to guide therapeutic adjustments and dietary modifications. However, these laboratory values must always be interpreted alongside your complete clinical history. Never discontinue or alter prescribed medications without consulting your treating physician.”
— Dr. Ajay Singh, General Practitioner | DHA Registration ID: 36234132
Medication Safety Advisory
⚠️ Important Notice
Do not discontinue, adjust, or modify any prescribed medication (including potassium citrate, thiazides, or allopurinol) without explicit instruction from your treating physician. Abrupt changes may provoke stone formation or metabolic complications. Always consult your doctor before making any changes to your medication regimen.
Exclusion Criteria & Emergency Red Flags
Exclusion: Active symptomatic urinary tract infection (fever, dysuria), inability to perform 24-hour urine collection, severe cognitive impairment without caregiver assistance.
Seek Emergency Care if you experience: sudden inability to urinate, severe flank pain with nausea or vomiting, high fever with chills, or visible blood clots in urine while preparing for the test.
Patient FAQ & Clinical Guidance
1. What does the Kidney Stone Formation Therapeutic Monitoring Panel measure?
This panel quantifies key urinary lithogenic and inhibitory factors including calcium, oxalate, citrate, uric acid, pH, sodium, potassium, chloride, phosphorus, and magnesium. Results guide your physician in adjusting therapy and dietary recommendations for recurrent nephrolithiasis management.
2. How do I properly collect the 24-hour urine specimen?
Collect all urine over 24 hours into two provided containers—one non-acidified and one acidified (containing 25 mL 50% HCl to maintain pH below 3). Refrigerate both containers throughout collection. Ship frozen and never thaw. Your body weight must be recorded on the request form. Detailed printed instructions accompany the collection kit.
3. Can I take my usual medications and supplements before the test?
Do not discontinue any prescribed medication without your doctor's approval. Avoid high-dose vitamin C exceeding 1000 mg and calcium supplements for 48 hours prior to collection unless otherwise directed. Our clinical team will review your complete medication and supplement list during scheduling.
UAE Regulatory & Data Privacy Adherence
COMPLIANCE FRAMEWORK
This diagnostic service strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols comply with Federal Decree-Law No. 4 of 2016 on Medical Liability. Facility License: DHA-1143. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | Kidney Stone Formation Therapeutic Monitoring Panel |
| Price (AED) | 1000 |
| Turnaround Time | Same Day (sample submission by 9 AM Wed/Sat) |
| Sample Type / Matrix | 24-Hour Urine Collection (two containers: non-acidified and acidified) |
| Methodology Used | Spectrophotometry, Enzymatic, Indirect Ion-Selective Electrode (ISE) |
| ICD-10-CM Code | N20.0 |
| LOINC Code | 74825-1 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Brand: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians